PA
GGB icon

PharVision Advisers’s Gerdau GGB Stock Holding History

PharVision Advisers’s Portfolio GGB Stock Details GGB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Buy
+27,702
New +$123K 2.11% 11
2026
Q1 		– Sell
-27,308
Closed -$101K – 324
2025
Q4 		$101K Buy
27,308
+5,240
+24% +$18.3K 0.05% 655
2025
Q3 		$68.4K Buy
+22,068
New +$66.8K 0.04% 641

Other funds holding GGB

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
CCM
Contrarian Capital Management Greenwich, Connecticut $306M AUM 23.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.65B AUM 47.79% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PharVision Advisers's GGB Position: Q2 2026 in Review

PharVision Advisers opened a new position in Gerdau (GGB) in Q2 2026: 27,702 shares worth $112K. The stake represents 2.11% of the portfolio and ranks #11 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in GGB as recently as Q4 2025.

PharVision Advisers first reported a position in GGB in Q3 2025 and has held it in 3 quarters since. 212 funds tracked by Wall St. Rank hold GGB as of Q2 2026.

  • PharVision Advisers held 27,702 shares of Gerdau worth $112K as of Q2 2026.
  • Gerdau was a new PharVision Advisers position in Q2 2026.
  • Gerdau made up 2.11% of PharVision Advisers's portfolio in Q2 2026, its #11 holding.
  • PharVision Advisers first reported a position in Gerdau in Q3 2025 and has held it in 3 quarters since.
  • 212 funds tracked by Wall St. Rank held Gerdau as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.